Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice by Shunji Nishide, Junji Uchida, Shinji Matsunaga, Kentaro Tokudome, Takehiro Yamaguchi, Kazuya Kabei, Taiki Moriya, Katsuyuki Miura, Tatsuya Nakatani, Shuhei Tomita

Connect to this object online.

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study by Taro Kishi, Kenji Sakuma, Makoto Okuya, Kohei Ninomiya, Kazuto Oya, Momoko Kubo, Yuki Matsui, Ikuo Nomura, Yuji Okuyama, Shinji Matsunaga, Nakao Iwata

Connect to this object online.

Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model by Kazuya Kabei, Yu Tateishi, Masayuki Shiota, Mayuko Osada-Oka, Shunji Nishide, Junji Uchida, Tatsuya Nakatani, Shinji Matsunaga, Takehiro Yamaguchi, Shuhei Tomita, Katsuyuki Miura

Connect to this object online.

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4 by Takehiro Yamaguchi, Ayano Watanabe, Masako Tanaka, Masayuki Shiota, Mayuko Osada-Oka, Soichi Sano, Minoru Yoshiyama, Katsuyuki Miura, Shojiro Kitajima, Shinji Matsunaga, Shuhei Tomita, Hiroshi Iwao, Yasukatsu Izumi

Connect to this object online.